VASOVaso Corporation

About Vaso Corporation (VASO)

Vaso Corporation (VASO) is a Health Information Services company headquartered in Plainview, NY, United States whose shares trade over-the-counter on the OTCQX tier.

Vaso Corporation principally operates in three distinct business segments in the healthcare equipment and information technology industries. We manage and evaluate our operations, and report our financial results, through these three business segments. IT segment, operating through a wholly-owned subsidiary VasoTechnology, Inc., primarily focuses on healthcare IT and managed network technology services; Professional sales service segment, operating through a wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for General Electric Healthcare ("GEHC") into the health provider middle market; and Equipment segment, primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through a wholly-owned subsidiary VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.

Products and services

VasoTechnology uses a combination of proprietary technology, methodology and best-in-class third-party applications to deliver its value proposition. Its current offering includes: • Managed diagnostic imaging applications (channel partner of select vendors of healthcare IT products). • Managed network infrastructure (routers, switches and other core equipment). • Managed network transport (FCC licensed carrier reselling 175+ facility partners). • Managed security services. VasoHealthcare current services include: • GEHC diagnostic imaging capital equipment. • GEHC service agreements for the above equipment. • GEHC training services for use of the above equipment. • GEHC and third-party financial services for the above equipment. Vasomedical product offerings are: • Biox™ series Holter monitors and ambulatory blood pressure recorders. • ARCS™ series analysis, reporting and communication software for ECG and blood pressure signals, including cloud-based software suite and algorithm subscription services.. • MobiCare® multi-parameter wireless vital-sign monitoring system. • EECP® therapy systems for non-invasive, outpatient treatment of ischemic heart disease.

VASO key facts

Ticker symbol

VASO

Market tier

OTCQX

Sector

Healthcare

Industry

Health Information Services

Headquarters

Plainview, NY, United States

Country of incorporation

US

Year of incorporation

1987

Employees

256

Estimated market cap

$23.67M (as of Apr 11, 2025)

Shares outstanding

175,697,311

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Vaso Corporation leadership

• Jun Ma — President, CEO
• Peter C. Castle — President, Subsidiary
• Jane Moen — President, Subsidiary, COO
• Jonathan P. Newton — CFO, Treasurer, Secretary
• Michael Beecher — Financial Advisor

Explore more: Health Information Services stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with V